# Elena Zakharova

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/elena-zakharova/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,310 |
| Field | Pregnancy and Medication Impact |
| h-index | 35 |
| i10-index | 52 |
| Last Known Institution | Russian Medical Academy of Continuous Professional Education |
| OpenAlex ID | https://openalex.org/A5034644063 |
| ORCID iD | 0000-0003-0178-7549 |
| Works | 264 |

## Researcher papers

- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [Treat-to-target in systemic lupus erythematosus: recommendations from an international task force](https://scholariq.org/papers/treat-to-target-in-systemic-lupus-erythematosus-recommendations-from-an/)
- [Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/iron-management-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/dialysis-initiation-modality-choice-access-and-prescription-conclusions-from-a/)
- [COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration](https://scholariq.org/papers/covid-19-related-mortality-in-kidney-transplant-and-dialysis-patients-results-of/)
- [A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)](https://scholariq.org/papers/a-framework-for-remission-in-sle-consensus-findings-from-a-large-international/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Increasing access to integrated ESKD care as part of universal health coverage](https://scholariq.org/papers/increasing-access-to-integrated-eskd-care-as-part-of-universal-health-coverage/)
- [A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial](https://scholariq.org/papers/a-novel-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-gsk1278863-for/)
- [International consensus definitions of clinical trial outcomes for kidney failure: 2020](https://scholariq.org/papers/international-consensus-definitions-of-clinical-trial-outcomes-for-kidney/)
- [Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings](https://scholariq.org/papers/challenges-in-diagnosis-and-management-of-glomerular-disease-in-resource-limited/)

## Researcher topics

- [Pregnancy and Medication Impact](https://scholariq.org/topics/pregnancy-and-medication-impact/)
- [Pregnancy and preeclampsia studies](https://scholariq.org/topics/pregnancy-and-preeclampsia-studies/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Russian Medical Academy of Continuous Professional Education](https://scholariq.org/institutions/russian-medical-academy-of-continuous-professional-education/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.